Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-06

Clinical Trial Update: FDA: Lowering Orthopedic Opioid Dosing (FLOOD) [NA]

View source ↗

Summary

The FLOOD trial, sponsored by Kaiser Permanente, investigated lowering opioid dosing for postoperative pain in orthopedic patients. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kaiser Permanente | Conditions: Post-operative Pain | NA | Status: COMPLETED